drugset / Trial / NCT06214858
The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to evaluate the safety, tolerability, pharmacokinetics, and food effects of SHEN211 tablet in healthy subjects after fasting single or multiple oral administration
Timeline
- Start
- 2023-12-14
- Primary completion
- 2024-04-02
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHEN211 | Unknown | 110 mg | Oral |
| Subject | SHEN211 | Unknown | 220 mg | Oral |
| Subject | SHEN211 | Unknown | 330 mg | Oral |
| Subject | SHEN211 | Unknown | 550 mg | Oral |
| Subject | SHEN211 | Unknown | 770 mg | Oral |
Indications
No indication recorded.